Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC789023893;23894;23895 chr2:178719824;178719823;178719822chr2:179584551;179584550;179584549
N2AB757322942;22943;22944 chr2:178719824;178719823;178719822chr2:179584551;179584550;179584549
N2A664620161;20162;20163 chr2:178719824;178719823;178719822chr2:179584551;179584550;179584549
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: R
  • RefSeq wild type transcript codon: AGA
  • RefSeq wild type template codon: TCT
  • Domain: Ig-64
  • Domain position: 2
  • Structural Position: 2
  • Q(SASA): 0.7053
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
R/G rs1356279706 -0.341 0.024 N 0.281 0.265 0.40032279838 gnomAD-2.1.1 4.14E-06 None None None None N None 0 0 None 0 0 None 0 None 0 9.15E-06 0
R/I rs370939248 0.5 0.029 N 0.385 0.332 None gnomAD-2.1.1 1.24E-05 None None None None N None 0 0 None 0 0 None 0 None 0 2.75E-05 0
R/I rs370939248 0.5 0.029 N 0.385 0.332 None gnomAD-3.1.2 1.31E-05 None None None None N None 0 0 0 0 0 None 0 0 2.94E-05 0 0
R/I rs370939248 0.5 0.029 N 0.385 0.332 None gnomAD-4.0.0 1.55928E-05 None None None None N None 1.34485E-05 1.70097E-05 None 0 0 None 0 0 1.78882E-05 0 3.22924E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
R/A 0.1785 likely_benign 0.1496 benign -0.07 Destabilizing 0.007 N 0.216 neutral None None None None N
R/C 0.1258 likely_benign 0.1257 benign -0.197 Destabilizing 0.676 D 0.279 neutral None None None None N
R/D 0.3669 ambiguous 0.333 benign 0.004 Stabilizing 0.072 N 0.382 neutral None None None None N
R/E 0.1651 likely_benign 0.1479 benign 0.066 Stabilizing 0.016 N 0.233 neutral None None None None N
R/F 0.3473 ambiguous 0.3078 benign -0.299 Destabilizing 0.214 N 0.323 neutral None None None None N
R/G 0.1444 likely_benign 0.1267 benign -0.263 Destabilizing 0.024 N 0.281 neutral N 0.486150537 None None N
R/H 0.0813 likely_benign 0.082 benign -0.696 Destabilizing 0.356 N 0.379 neutral None None None None N
R/I 0.1262 likely_benign 0.1119 benign 0.403 Stabilizing 0.029 N 0.385 neutral N 0.498178405 None None N
R/K 0.0809 likely_benign 0.0708 benign -0.078 Destabilizing None N 0.139 neutral N 0.434932777 None None N
R/L 0.1372 likely_benign 0.1252 benign 0.403 Stabilizing 0.016 N 0.285 neutral None None None None N
R/M 0.1355 likely_benign 0.1145 benign 0.021 Stabilizing 0.356 N 0.329 neutral None None None None N
R/N 0.2879 likely_benign 0.237 benign 0.176 Stabilizing 0.072 N 0.258 neutral None None None None N
R/P 0.8429 likely_pathogenic 0.8116 pathogenic 0.266 Stabilizing 0.136 N 0.396 neutral None None None None N
R/Q 0.0731 likely_benign 0.0703 benign 0.048 Stabilizing 0.003 N 0.18 neutral None None None None N
R/S 0.2041 likely_benign 0.174 benign -0.239 Destabilizing 0.002 N 0.191 neutral N 0.470989578 None None N
R/T 0.1027 likely_benign 0.0834 benign -0.043 Destabilizing None N 0.183 neutral N 0.414405577 None None N
R/V 0.1556 likely_benign 0.1361 benign 0.266 Stabilizing None N 0.267 neutral None None None None N
R/W 0.136 likely_benign 0.1352 benign -0.323 Destabilizing 0.864 D 0.285 neutral None None None None N
R/Y 0.2468 likely_benign 0.2245 benign 0.087 Stabilizing 0.356 N 0.359 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.